Therapix Biosciences Ltd.
Major Drugs - Tel-Aviv, , IL
Therapix Biosciences Ltd. Employees
Therapix Biosciences Ltd. Senior Management
Therapix Biosciences Ltd. Details
Therapix Biosciences Ltd. (NASDAQ: TRPX) is a specialty clinical-stage pharmaceutical company led by an experienced team of Senior Executives and Scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals.With this focus, the company is currently engaged in the following drug development programs based on repurposing an FDA-approved cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
Therapix Biosciences Ltd. Technologies
Email Providers
Outlook
Load Balancers
Apache
CMS
WordPress.org
Fonts
Google Font API
Other
Microsoft Office 365
Analytics and Tracking
Google Analytics